B. Lashner

发表

In vivo colonoscopic optical coherence tomography for transmural inflammation in inflammatory bowel disease.

Gregory Zuccaro, Felix Feldchtein, J. Connor, 2004, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

The London Position Statement of the World Congress of Gastroenterology on Biological Therapy for IBD With the European Crohn's and Colitis Organization: When to Start, When to Stop, Which Drug to Choose, and How to Predict Response?

S. Schreiber, S. Vermeire, D. Hommes, 2011, The American Journal of Gastroenterology.

Optimal Bowel Preparation for Colonoscopy

B. Lashner, A. Atreja, Sansrita Nepal, 2011 .

Prior esophageal variceal bleeding does not adversely affect survival after orthotopic liver transplantation

J. Emond, A. Baker, B. Lashner, 1993, Hepatology.

CHAPTER 36 – MEDICAL TREATMENT OF ULCERATIVE COLITIS AND OTHER COLITIDES

B. Lashner, A. Brzezinski, 2004 .

Left-sided ulcerative colitis.

B. Lashner, D. Haghighi, 2004, Gastroenterology clinics of North America.

Inflammatory bowel disease: sorting out the treatment options.

B. Lashner, J. Wolf, 2002, Cleveland Clinic journal of medicine.

Industrial Risk Factors for Colorectal Cancer

S. Epstein, B. Lashner, S. Epstein, 1990, International journal of health services : planning, administration, evaluation.

Cytomegalovirus Colitis Complicating Inflammatory Bowel Disease

B. Lashner, A. Kandiel, 2006, The American Journal of Gastroenterology.

Crohn's Disease

B. Lashner, A. Brzezinski, 2010 .

Chemoprevention of colorectal cancer: slow, steady progress.

C. Burke, B. Lashner, W. Bauer, 2003, Cleveland Clinic journal of medicine.

Making the most of currently available bowel preparations for colonoscopy

B. Lashner, A. Atreja, Sansrita Nepal, 2010, Cleveland Clinic Journal of Medicine.

Surveillance for Neoplasia in the Patient with an Ileal Pouch

B. Lashner, R. Kariv, 2015 .

Using Technology to Promote Gastrointestinal Outcomes Research: A Case for Electronic Health Records

J. Achkar, Anil K. Jain, B. Lashner, 2008, The American Journal of Gastroenterology.

Safety of infliximab: Primum non nocere

B. Lashner, M. Parsi, 2004 .

Optical coherence tomography (OCT) via colonoscopy to detect transmural inflammation in Crohn's colitis (CC)

J. Connor, V. Fazio, D. Conwell, 2003 .

Colorectal Cancer in Ulcerative Colitis: Surveillance

A. Watson, P. Collins, B. Lashner, 2010 .

Gastrointestinal manifestations of COVID-19.

J. Achkar, B. Lashner, M. Regueiro, 2020, Cleveland Clinic journal of medicine.

Advances in Ulcerative Colitis Diagnosis and Management CME Certified Activity

B. Lashner, K. Das, 2006 .

Sensitivity–Specificity Trade-off for Capsule Endoscopy in IBD: Is It Worth It?

B. Lashner, 2006, The American Journal of Gastroenterology.

Progressive primary sclerosing cholangitis requiring liver transplantation is associated with reduced need for colectomy in patients with ulcerative colitis.

F. Remzi, J. Fung, U. Navaneethan, 2012, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

Severity of primary sclerosing cholangitis and its impact on the clinical outcome of Crohn's disease.

U. Navaneethan, R. Lopez, B. Shen, 2012, Journal of Crohn's & colitis.

Randomized clinical trial of two colonoscopy preparation methods for elderly patients.

C. Winans, M. Blackstone, B. Lashner, 1990, Journal of clinical gastroenterology.

Pericholangitis and sclerosing cholangitis are risk factors for dysplasia and cancer in ulcerative colitis.

G. D'Haens, B. Lashner, S. B. Hanauer, 1993, The American journal of gastroenterology.

Risk Factors for Low Bone Mass in Patients With Ulcerative Colitis Following Ileal Pouch-Anal Anastomosis

V. Fazio, F. Remzi, I. Oikonomou, 2009, The American Journal of Gastroenterology.

Quality Commitment: The Newly Established American College of Gastroenterology Quality Council to Meet the Needs of Clinical Gastroenterology

J. Leighton, D. Johnson, I. Pike, 2013, The American Journal of Gastroenterology.

Cigarette smoking in Crohn's disease.

S. Hanauer, J. Kirsner, M. Silverstein, 1989, The American journal of gastroenterology.

The risk of cancer and dysplasia among ulcerative colitis patients with primary sclerosing cholangitis.

J. Church, V. Fazio, I. Lavery, 1997, The American journal of gastroenterology.

Abnormal p53 Immunohistochemistry Is Associated With An Increased Colorectal Cancer–Related Mortality in Patients With Ulcerative Colitis

J. Goldblum, L. Rybicki, B. Lashner, 2003, American Journal of Gastroenterology.

True or False? The Hygiene Hypothesis for Crohn's Disease

E. Loftus, B. Lashner, 2006, The American Journal of Gastroenterology.

The epidemiology of inflammatory bowel disease: are we learning anything new?

J. Kirsner, B. Lashner, 1992, Gastroenterology.

Risk of Colonic Neoplasia After Liver Transplantation for Primary Sclerosing Cholangitis

R. Lopez, B. Lashner, I. Hanouneh, 2012, Inflammatory bowel diseases.

Risk factors for diseases of ileal pouch-anal anastomosis after restorative proctocolectomy for ulcerative colitis.

J. Achkar, C. Delaney, V. Fazio, 2006, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

Intestinal adenocarcinoma in Crohn's disease: a report of 30 cases with a focus on coexisting dysplasia.

J. Goldblum, V. Fazio, R. Petras, 1999, The American journal of surgical pathology.

Epidemiology of inflammatory bowel disease.

B. Lashner, 1995, Gastroenterology clinics of North America.

Comprehensive Evaluation of Inflammatory and Noninflammatory Sequelae of Ileal Pouch-Anal Anastomoses

J. Achkar, C. Delaney, V. Fazio, 2005, The American Journal of Gastroenterology.

Optimal timing of colonoscopy to screen for cancer in ulcerative colitis.

S. Hanauer, M. Silverstein, B. Lashner, 1988, Annals of internal medicine.

Combined Ciprofloxacin and Tinidazole Therapy in the Treatment of Chronic Refractory Pouchitis

V. Fazio, F. Remzi, I. Oikonomou, 2007, Diseases of the colon and rectum.

Clinical Approach to Diseases of Ileal Pouch-Anal Anastomosis

V. Fazio, F. Remzi, B. Shen, 2005, The American Journal of Gastroenterology.

The effects of an oral supplement enriched with fish oil, prebiotics, and antioxidants on nutrition status in Crohn's disease patients.

D. Seidner, E. Lerner, B. Lashner, 2011, Nutrition in clinical practice : official publication of the American Society for Parenteral and Enteral Nutrition.

Safety and Efﬁcacy of Recombinant Human Interleukin 10 in Chronic Active Crohn’s Disease

O. Nielsen, S. Nikolaus, S. V. Deventer, 2000 .

Local Stem Cell Therapy for Crohn's Perianal Fistulae.

B. Shen, B. Lashner, A. Lightner, 2018, Inflammatory bowel diseases.

Chronic respiratory distress, dyspepsia, and diarrhea: What is the connection?

J. Goldblum, D. Conwell, A. Lichtin, 1998, Journal of clinical gastroenterology.

Recurrence of Crohn's Disease After Small Bowel Transplantation: Fact or Fiction.

C. Fiocchi, K. Abu-Elmagd, B. Lashner, 2019, Inflammatory bowel diseases.

B. Shen, B. Lashner, A. Atreja, 2013, Digestive Diseases and Sciences.

Cigarette smoking and ulcerative colitis: a case-control study.

M. Silverstein, B. Lashner, S. B. Hanauer, 1994, Mayo Clinic proceedings.

Testing nicotine gum for ulcerative colitis patients

S. Hanauer, M. Silverstein, B. Lashner, 1990, Digestive Diseases and Sciences.

The impact of ursodeoxycholic acid on cancer, dysplasia and mortality in ulcerative colitis patients with primary sclerosing cholangitis

L. Rybicki, J. Wolf, B. Lashner, 2005, Alimentary pharmacology & therapeutics.

Treatment of Rectal Cuff Inflammation (Cuffitis) in Patients with Ulcerative Colitis Following Restorative Proctocolectomy and Ileal Pouch-Anal Anastomosis

J. Achkar, V. Fazio, F. Remzi, 2004, American Journal of Gastroenterology.

Irritable pouch syndrome: a new category of diagnosis for symptomatic patients with ileal pouch-anal anastomosis

J. Achkar, V. Fazio, F. Remzi, 2002, American Journal of Gastroenterology.

An uncommon presentation of a common diagnosis: nausea and abdominal pain in thyrotoxicosis

B. Lashner, Abdullah Shatnawei, D. Kirby, 2009 .

A safety and efficacy study of recombinant human interleukin-10 (rHuIL-10) treatment in 329 patients with chronic active Crohn's disease (CACD)

S. Hanauer, O. Nielsen, G. Wild, 1998 .

Induction of Remission with 5-Aminosalicylic Agents for Ulcerative Colitis Patients

B. Lashner, 2010 .

The effects of liver transplantation on the clinical course of colitis in ulcerative colitis patients with primary sclerosing cholangitis

F. Remzi, U. Navaneethan, B. Shen, 2012, Alimentary pharmacology & therapeutics.

Type of Fistula Determines Response to Infliximab in Patients with Fistulous Crohn's Disease

J. Connor, J. Achkar, B. Lashner, 2004, American Journal of Gastroenterology.

Passive smoking is associated with an increased risk of developing inflammatory bowel disease in children.

B. Kirschner, S. Hanauer, N. Shaheen, 1993, The American journal of gastroenterology.

Real-World Effectiveness and Safety of Ustekinumab in Elderly Crohn’s Disease Patients

M. Regueiro, J. Achkar, F. Rieder, 2021, Digestive Diseases and Sciences.

Mild neoterminal ileal post‐operative recurrence of Crohn’s disease conveys higher risk for severe endoscopic disease progression than isolated anastomotic lesions

M. Regueiro, J. Achkar, E. Barnes, 2022, Alimentary pharmacology & therapeutics.

Human recombinant interleukin-10 is safe and well tolerated but does not induce remission in steroid dependent Crohn's disease

A. Forbes, A. Buchman, O. Nielsen, 2001 .

Recommendations for colorectal cancer screening in ulcerative colitis: a review of research from a single university-based surveillance program.

B. Lashner, 1992, The American journal of gastroenterology.

Association Between Immune-Associated Disorders and Adverse Outcomes of Ileal Pouch-Anal Anastomosis

V. Fazio, F. Remzi, I. Lavery, 2009, The American Journal of Gastroenterology.

Maintenance therapy with a probiotic in antibiotic‐dependent pouchitis: experience in clinical practice

J. Achkar, V. Fazio, F. Remzi, 2005, Alimentary pharmacology & therapeutics.

Cancer in inflammatory bowel disease

B. Lashner, 1991 .

Endoscopic Balloon Dilation of Ileal Pouch Strictures

J. Achkar, C. Delaney, V. Fazio, 2004, The American Journal of Gastroenterology.

Once-daily dosing of delayed-release oral mesalamine (400-mg tablet) is as effective as twice-daily dosing for maintenance of remission of ulcerative colitis.

J. Korzenik, J. Leighton, D. Ramsey, 2010, Gastroenterology.

Inflammatory bowel disease in older people.

J. Kirsner, B. Lashner, 1991, Clinics in geriatric medicine.

Dysplasia and cancer complicating strictures in ulcerative colitis

D. Bostwick, S. Hanauer, B. Turner, 1990, Digestive Diseases and Sciences.

Cigarette smoking and endometrial cancer.

S. Shapiro, S. Hanauer, S. Lesko, 1986 .

Measurement of nutrition status in Crohn's disease patients receiving infliximab therapy.

D. Seidner, B. Lashner, Dawn M. Wiese, 2008, Nutrition in clinical practice : official publication of the American Society for Parenteral and Enteral Nutrition.

Mesalamine for prophylaxis of small bowel Crohn’s disease recurrence

B. Lashner, W. Bauer, A. Brzezinski, 1999, Current gastroenterology reports.

Safety and efficacy of endoscopic dilation for primary and anastomotic Crohn's disease strictures.

F. Rieder, J. Vargo, R. Lopez, 2014, Journal of Crohn's & colitis.

CLINICAL—ALIMENTARY TRACT Once-Daily Dosing of Delayed-Release Oral Mesalamine (400-mg Tablet) Is as Effective as Twice-Daily Dosing for Maintenance of Remission of Ulcerative Colitis

J. Korzenik, J. Leighton, D. Ramsey, 2010 .

Doubling the infliximab dose versus halving the infusion intervals in Crohn's disease patients with loss of response

J. Gisbert, P. Higgins, A. Hart, 2012, Inflammatory bowel diseases.

Impact of Low Immunoglobulin G Levels on Disease Outcomes in Patients with Inflammatory Bowel Diseases

J. Achkar, A. Garber, B. Shen, 2016, Digestive Diseases and Sciences.

Clinical Features and Quality of Life in Patients with Different Phenotypes of Crohn’s Disease of the Ileal Pouch

V. Fazio, F. Remzi, I. Lavery, 2007, Diseases of the colon and rectum.

Effect of Withdrawal of Nonsteroidal Anti-Inflammatory Drug Use on Ileal Pouch Disorders

V. Fazio, F. Remzi, I. Lavery, 2007, Digestive Diseases and Sciences.

Use of old and new oral 5-aminosalicylic acid formulations in inflammatory bowel disease.

D. Seidner, B. Lashner, A. Brzezinski, 1995, Cleveland Clinic journal of medicine.

An oral supplement enriched with fish oil, soluble fiber, and antioxidants for corticosteroid sparing in ulcerative colitis: a randomized, controlled trial.

J. Goldblum, D. Seidner, C. Fiocchi, 2005, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

The impact of ulcerative colitis on the long‐term outcome of patients with primary sclerosing cholangitis

U. Navaneethan, B. Shen, B. Lashner, 2012, Alimentary pharmacology & therapeutics.

Fecal lactoferrin for diagnosis of symptomatic patients with ileal pouch-anal anastomosis.

J. Goldblum, J. Connor, J. Achkar, 2004, Gastroenterology.

Temporal trends in colon neoplasms in patients with primary sclerosing cholangitis and ulcerative colitis.

F. Remzi, U. Navaneethan, B. Shen, 2012, Journal of Crohn's & colitis.

Cancer surveillance in patients with ulcerative colitis.

S. Hanauer, J. Kirsner, M. Silverstein, 1988, The New England journal of medicine.

A case of refractory diarrhea.

B. Lashner, J. Isaacson, J. Monti, 2008, Cleveland Clinic journal of medicine.

Infliximab is more efficacious for treatment of enterocutaneous fistulas compared to rectovaginal fistulas in patients with Crohn's disease

J. Achkar, B. Lashner, M. Parsi, 2001 .

Clinical approach to colonic ischemia

B. Lashner, Firas Al Solaiman, K. Elder, 2009, Cleveland Clinic Journal of Medicine.

Collagenous sprue: a case report and literature review.

M. Bronner, B. Lashner, D. Kirby, 2009, Gastroenterology & hepatology.

Adenocarcinoma complicating Crohn's disease

G. Testa, B. Lashner, F. Michelassi, 1993, Diseases of the colon and rectum.

Informed Consent in IBD Trials: Where We Are and Where We Need to Go.

E. Kodish, B. Lashner, J. Katz, 2019, Inflammatory bowel diseases.

Short chain fatty acid rectal irrigation for left-sided ulcerative colitis: a randomised, placebo controlled trial.

A. Rademaker, A. Keshavarzian, S. Hanauer, 1997, Gut.

Bioavailability of magnesium diglycinate vs magnesium oxide in patients with ileal resection.

B. Lashner, S. Schuette, M. Janghorbani, 1994, JPEN. Journal of parenteral and enteral nutrition.

Use of Infliximab within 3 Months of Ileocolonic Resection is Associated with Adverse Postoperative Outcomes in Crohn’s Patients

J. Church, V. Fazio, F. Remzi, 2008, Journal of Gastrointestinal Surgery.

Reviewing the Risk of Colorectal Cancer in Inflammatory Bowel Disease After Liver Transplantation for Primary Sclerosing Cholangitis.

K. Kowdley, B. Rao, B. Lashner, 2018, Inflammatory bowel diseases.

Inflammatory Bowel Disease and Irritable Bowel Syndrome: What to Do When There Is an Overlap.

B. Lashner, R. Padival, Afrin N. Kamal, 2018, Inflammatory bowel diseases.

Chronic hepatitis: disease factors at diagnosis predictive of mortality.

H. S. Tang, A. Baker, B. Lashner, 1988, The American journal of medicine.

Acute pancreatitis associated with high-concentration lipid emulsion during total parenteral nutrition therapy for Crohn's disease.

S. Hanauer, J. Kirsner, B. Lashner, 1986, Gastroenterology.

Infliximab maintenance therapy for fistulizing Crohn's disease.

P. Rutgeerts, M. Kamm, C. Bernstein, 2004, The New England journal of medicine.

Natalizumab for the treatment of active Crohn's disease: results of the ENCORE Trial.

S. Targan, P. Rutgeerts, M. Spehlmann, 2007, Gastroenterology.

Safety and efficacy of recombinant human interleukin 10 in chronic active Crohn's disease. Crohn's Disease IL-10 Cooperative Study Group.

P. Rutgeerts, S. Hanauer, O. Nielsen, 2000, Gastroenterology.

SER-109, an Oral Microbiome Therapy for Recurrent Clostridioides difficile Infection.

J. Wortman, M. Henn, T. Louie, 2022, The New England journal of medicine.

Commentary and analysis on advances in the understanding and management of inflammatory bowel disease

M. Neurath, J. Milsom, I. Atreya, 2006 .

Severe complications of inflammatory bowel disease.

M. Qadeer, B. Lashner, Francisco J. Marrero, 2008, The Medical clinics of North America.

A proposed classification of ileal pouch disorders and associated complications after restorative proctocolectomy.

V. Fazio, F. Remzi, I. Lavery, 2008, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

The risk for cancer or dysplasia in ulcerative colitis patients with primary sclerosing cholangitis

K. Shetty, L. Rybicki, B. Lashner, 1999, American Journal of Gastroenterology.

Random versus targeted biopsies for colorectal cancer surveillance in inflammatory bowel disease.

B. Lashner, T. Ahmed, J. Monti, 2010, Gastroenterology & hepatology.

Colorectal cancer surveillance for patients with inflammatory bowel disease.

B. Lashner, 2002, Gastrointestinal endoscopy clinics of North America.

Colorectal cancer in ulcerative colitis patients: survival curves and surveillance.

B. Lashner, 1994, Cleveland Clinic journal of medicine.

Risk factors for small bowel cancer in Crohn's disease

B. Lashner, 1992, Digestive diseases and sciences.

Sarcoidosis presenting as granulomatous colitis

R. Petras, B. Lashner, J. Dumot, 1998, American Journal of Gastroenterology.

Evaluation of the usefulness of testing for p53 mutations in colorectal cancer surveillance for ulcerative colitis

J. Goldblum, A. Husain, B. Lashner, 1999, American Journal of Gastroenterology.

Colon cancer surveillance in chronic ulcerative colitis: historical cohort study.

S. Kane, B. Lashner, S. Hanauer, 1990, The American journal of gastroenterology.

Cancer biology in ulcerative colitis and potential use in endoscopic surveillance.

B. Lashner, B. Shapiro, 1997, Gastrointestinal endoscopy clinics of North America.

Hazard rates for dysplasia and cancer in ulcerative colitis

S. Hanauer, M. Silverstein, B. Lashner, 1989, Digestive Diseases and Sciences.

Abnormal p53 immunohistochemistry is associated with an increased colorectal cancer-related mortality in patients with ulcerative colitis.

J. Goldblum, L. Rybicki, B. Lashner, 2003 .

Ganglioneuromatosis of the colon and extensive glygogenic acanthosis in Cowden's disease

C. Winans, R. Riddell, B. Lashner, 1986, Digestive Diseases and Sciences.

Hospital Readmissions in Patients With Inflammatory Bowel Disease

Rocio Lopez, R. Lopez, B. Lashner, 2013, The American Journal of Gastroenterology.

Differentiating risk factors for acute and chronic pouchitis.

M. Al-Haddad, J. Achkar, V. Fazio, 2005, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

For Pancreatitis in Inflammatory Bowel Disease, Treat the Bowel

D. Conwell, B. Lashner, 1999, American Journal of Gastroenterology.

Modified Pouchitis disease activity index: A simplified approach to the diagnosis of pouchitis

J. Connor, J. Achkar, V. Fazio, 2003 .

Endoscopic and histologic evaluation together with symptom assessment are required to diagnose pouchitis.

J. Achkar, V. Fazio, F. Remzi, 2001, Gastroenterology.

Clinical Features of Ileal Pouch Polyps in Patients with Underlying Ulcerative Colitis

V. Fazio, F. Remzi, B. Shen, 2007, Diseases of the colon and rectum.

Diagnosis and treatment of ileal pouch diseases in patients with underlying ulcerative colitis

B. Shen, B. Lashner, 2006, Current treatment options in gastroenterology.

Conflicts of Interest in Clinical Practice Guidelines.

F. Cominelli, B. Lashner, 2018, Inflammatory bowel diseases.

Difficulty swallowing solid foods; food ‘getting stuck in the chest’

B. Lashner, D. Kirby, Bijo K. John, 2010, Cleveland Clinic Journal of Medicine.

Scheduled maintenance treatment with infliximab is superior to episodic treatment for the healing of mucosal ulceration associated with Crohn's disease

M. Bala, S. Hanauer, P. Rutgeerts, 2006 .

Indicators of Clinical Response to Treatment with Six-Mercaptopurine or Azathioprine in Patients with Inflammatory Bowel Disease

J. Achkar, D. Seidner, T. Stevens, 2004, Inflammatory bowel diseases.

Efficacy, Safety, and Long-term Outcome of Serial Endoscopic Balloon Dilation for Upper Gastrointestinal Crohn’s Disease-associated Strictures—A Cohort Study

F. Rieder, N. Agrawal, H. Kessler, 2017, Journal of Crohn's & colitis.

Scheduled maintenance treatment with infliximab is superior to episodic treatment for the healing of mucosal ulceration associated with Crohn's disease.

P. Rutgeerts, M. Bala, S. Hanauer, 2006, Gastrointestinal endoscopy.

Predictors of response to infliximab in patients with Crohn's disease.

J. Achkar, J. Hammel, B. Lashner, 2002, Gastroenterology.

Will a 5-ASA a Day Keep the Cancer (and Dysplasia) Away?

D. Rubin, B. Lashner, 2005, The American Journal of Gastroenterology.

Azathioprine formulation optimizes metabolite profile in inflammatory bowel disease

J. Achkar, T. Stevens, B. Lashner, 2004, Alimentary Pharmacology and Therapeutics.

Family history of Crohn's disease is associated with an increased risk for Crohn's disease of the pouch

V. Fazio, F. Remzi, C. Bevins, 2009, Inflammatory bowel diseases.

Clinical epidemiology of inflammatory bowel disease

Aaron Brzezinski, B. Lashner, Bret A. Lashner, 1994 .

A Randomized Clinical Trial of Ciprofloxacin and Metronidazole to Treat Acute Pouchitis

J. Achkar, V. Fazio, F. Remzi, 2001, Inflammatory bowel diseases.

Application of Wireless Capsule Endoscopy for the Evaluation of Iron Deficiency Anemia in Patients With Ileal Pouches

V. Fazio, F. Remzi, B. Shen, 2008, Journal of clinical gastroenterology.

Preoperative total parenteral nutrition for bowel resection in Crohn's disease

S. Hanauer, B. Lashner, A. Evans, 1989, Digestive Diseases and Sciences.

Risk factors for nephrolithiasis in patients with ileal pouches.

S. Mukewar, R. Lopez, B. Shen, 2013, Journal of Crohn's & colitis.

Risk Factors for Clinical Phenotypes of Crohn's Disease of the Ileal Pouch

V. Fazio, F. Remzi, I. Oikonomou, 2006, The American Journal of Gastroenterology.

Autoimmune Features Are Associated with Chronic Antibiotic-refractory Pouchitis

D. Seril, B. Shen, B. Lashner, 2015, Inflammatory bowel diseases.

Cost-effectiveness of Quantitative Fecal Lactoferrin Assay for Diagnosis of Symptomatic Patients With Ileal Pouch-anal Anastomosis

B. Lashner, M. Parsi, J. Ellis, 2008, Journal of clinical gastroenterology.

Pouchitis: A spectrum of diseases

B. Shen, B. Lashner, 2005, Current gastroenterology reports.

A Cost-Effectiveness Analysis of Diagnostic Strategies for Symptomatic Patients with Ileal Pouch-Anal Anastomosis

J. Achkar, V. Fazio, F. Remzi, 2003 .

A cost-effectiveness analysis of diagnostic strategies for symptomatic patients with ileal pouch–anal anastomosis

J. Achkar, V. Fazio, F. Remzi, 2003, American Journal of Gastroenterology.

Use of Biologics in Crohn’s Disease and Ulcerative Colitis Prior to Surgery and Perioperative Risks

B. Lashner, Afrin N. Kamal, 2018 .

90 Family History of Crohn's Disease Increases the Risk for the Development of Crohn's Disease of Ileal Pouch-Anal Anastomosis

V. Fazio, F. Remzi, B. Shen, 2008 .

Afferent limb ulcers predict Crohn's disease in patients with ileal pouch-anal anastomosis.

J. Goldblum, J. Connor, J. Achkar, 2004, Gastroenterology.

Modified Pouchitis Disease Activity Index

J. Connor, J. Achkar, V. Fazio, 2003, Diseases of the colon and rectum.

Adenocarcinoma in Ileal Pouch-Anal Anastomosis: The Cleveland Clinic Experience: 953

V. Fazio, F. Remzi, I. Lavery, 2007 .

Diagnosis and treatment of pouchitis.

B. Shen, B. Lashner, 2008, Gastroenterology & hepatology.

Risk Factors for Anemia in Patients with Ileal Pouch-Anal Anastomosis

V. Fazio, F. Remzi, I. Oikonomou, 2007, Diseases of the colon and rectum.

Early introduction of selective immunosuppressive therapy associated with favorable clinical outcomes in patients with immune checkpoint inhibitor–induced colitis

A. Jazaeri, R. Bresalier, Xuemei Wang, 2019, Journal of Immunotherapy for Cancer.

Manometric Evaluation of Evacuatory Difficulty (Dyschezia) in Ileal Pouch Patients

R. Khanna, B. Shen, B. Lashner, 2013, Inflammatory bowel diseases.

Irritable pouch syndrome: a new category of diagnosis for symptomatic patients with ileal pouch-anal anastomosis.

J. Achkar, V. Fazio, F. Remzi, 2002 .

Can We Immunogenotypically and Immunophenotypically Profile Patients Who are at Risk for Pouchitis?

B. Shen, B. Lashner, 2004, American Journal of Gastroenterology.

Ex vivo histology-correlated optical coherence tomography in the detection of transmural inflammation in Crohn's disease.

Gregory Zuccaro, Felix Feldchtein, J. Connor, 2004, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

Corrigendum to: Recurrence of Crohn's Disease After Small Bowel Transplantation: Fact or Fiction.

C. Fiocchi, K. Abu-Elmagd, B. Lashner, 2019, Inflammatory bowel diseases.

Once Daily Dosing of Delayed-Release Oral Mesalamine (400 mg Tablet) is as Effective as Twice Daily Dosing for Maintenance of Remission of Ulcerative Colitis: Results of the QDIEM Study: 1185

J. Korzenik, J. Leighton, D. Ramsey, 2009 .

Dual Targeted Therapy for the Management of Inflammatory Bowel Disease

B. Lashner, Mahnur Haider, 2021, Journal of clinical gastroenterology.

Molecular Pathways Underlying IBD-Associated Colorectal Neoplasia: Therapeutic Implications

J. Achkar, B. Lashner, A. Kandiel, 2011, The American Journal of Gastroenterology.

Rosiglitazone for active ulcerative colitis: a randomized placebo-controlled trial.

J. Ellenberg, S. Hanauer, B. Sands, 2008, Gastroenterology.

Intraabdominal septic complications after ileocolic resection increases risk for endoscopic and surgical postoperative Crohn's disease recurrence.

M. Regueiro, J. Achkar, E. Barnes, 2022, Journal of Crohn's & colitis.

Does length really matter? ... Oral and topical 5-aminosalicylic acid therapy for ulcerative colitis.

B. Lashner, 2002, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

P-0056: Pyloric gland metaplasia-a novel histological marker for Crohn's disease of the pouch and refractory pouchitis

J. Goldblum, R. Lopez, B. Shen, 2007 .

Pyloric gland metaplasia-a novel histological marker for Crohnʼs disease of the pouch and refractory pouchitis: P-0056

J. Goldblum, R. Lopez, B. Shen, 2007 .

Genetic Predictors of Crohnʼs Disease of the Ileal Pouch Anal Anastomosis: 2011 ACG IBD Award: 1211

J. Achkar, R. Lopez, B. Shen, 2011 .

Effect of folate supplementation on the incidence of dysplasia and cancer in chronic ulcerative colitis. A case-control study.

G. Su, P. Heidenreich, S. Hanauer, 1989, Gastroenterology.

Industrial exposure and colorectal cancer.

S. Epstein, B. Lashner, 1990, Journal of the National Cancer Institute.

Clostridium difficile culture-positive toxin-negative diarrhea.

S. Hanauer, D. Sahm, B. Lashner, 1986, The American journal of gastroenterology.

Safety and Tolerability of SER-109 as an Investigational Microbiome Therapeutic in Adults With Recurrent Clostridioides difficile Infection

C. Kelly, E. Hohmann, David A. Lombardi, 2023, JAMA network open.

Prevalence and incidence of inflammatory bowel disease in family members.

S. Hanauer, J. Kirsner, B. Lashner, 1986, Gastroenterology.

Implementation of Clinical Pharmacogenomics within a Large Health System: From Electronic Health Record Decision Support to Consultation Services

Charis Eng, Scott Knoer, David Stowe, 2016, Pharmacotherapy.

Red blood cell folate is associated with the development of dysplasia and cancer in ulcerative colitis

B. Lashner, 2005, Journal of Cancer Research and Clinical Oncology.

The effect of folic acid supplementation on the risk for cancer or dysplasia in ulcerative colitis.

D. Seidner, B. Lashner, A. Brzezinski, 1997, Gastroenterology.

Rosiglitazone for Active Ulcerative Colitis

J. Ellenberg, S. Hanauer, B. Sands, 2009 .

Test characteristics of cross-sectional imaging and concordance with endoscopy in postoperative Crohn's disease.

M. Regueiro, M. Baker, J. Achkar, 2021, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

Management of steroid-dependent and steroid-refractory ulcerative colitis

B. Lashner, Keely R. Parisian, 2014 .

Smoking and inflammatory bowel disease in families.

S. Hanauer, B. Lashner, M. Smith, 1988, The American journal of gastroenterology.

Medical Treatment of Crohn's Disease

B. Lashner, A. Brzezinski, 2001 .

Can patients reliably report quality indicators and disease phenotype? Results from the CrohnsPROMISE trial.: P-2.

J. Achkar, B. Shen, B. Lashner, 2011 .

Low Body Mass Index Can Identify Majority of Osteoporotic Inflammatory Bowel Disease Patients Missed by Current Guidelines

A. Licata, B. Lashner, A. Atreja, 2012, TheScientificWorldJournal.

6-Thioguanine levels versus white blood cell counts in guiding 6-mercaptopurine and azathioprine therapy

J. Achkar, D. Seidner, T. Stevens, 2000, American Journal of Gastroenterology.

Type of fistula determines-response to infliximab in patients with fistulous Crohn's disease

J. Connor, J. Achkar, B. Lashner, 2003 .

Lack of association between oral contraceptive use and Crohn's disease: a community-based matched case-control study.

S. Kane, B. Lashner, S. Hanauer, 1989, Gastroenterology.

Motion - colonoscopic surveillance is more cost effective than colectomy in patients with ulcerative colitis: Arguments for the motion.

B. Lashner, 2003, Canadian journal of gastroenterology = Journal canadien de gastroenterologie.

Safety and efficacy of recombinant human interleukin 10 in chronic active Crohn's disease. Crohn's Disease IL-10 Cooperative Study Group.

P. Rutgeerts, O. Nielsen, S. V. van Deventer, 2000, Gastroenterology.

Sigmoid volvulus as a complication of ileal Crohn's disease.

J. Kirsner, B. Lashner, S. Anastaplo, 1989, Journal of clinical gastroenterology.

Utility of Biomarkers in the Management of Inflammatory Bowel Disease

G. Kochhar, B. Lashner, 2017, Current Treatment Options in Gastroenterology.

Duration and severity of primary sclerosing cholangitis is not associated with risk of neoplastic changes in the colon in patients with ulcerative colitis.

F. Remzi, U. Navaneethan, G. Kochhar, 2012, Gastrointestinal endoscopy.

Ursodeoxycholic acid is not chemopreventive for colorectal cancer in ulcerative colitis patients with primary sclerosing cholangitis

L. Rybicki, B. Lashner, J. Wolf, 2001 .

Effects of immunosuppression and liver transplantation on inflammatory bowel disease in patients with primary sclerosing cholangitis.

U. Navaneethan, B. Lashner, 2013, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

Tolerability of iron: a comparison of bis-glycino iron II and ferrous sulfate.

B. Lashner, S. Schuette, G. Leichtmann, 1991, Clinical therapeutics.

Lack of association between oral contraceptive use and ulcerative colitis.

S. Hanauer, S. Kane, B. Lashner, 1990, Gastroenterology.

Su1869 Submucosal Fibrosis in Ulcerative Colitis Is Linked With Severity and Chronicity of Inflammation

C. Fiocchi, F. Rieder, N. Agrawal, 2016 .

1091 – Early Introduction of Non-Steroidal Immunosuppressive Therapy Associated with Favorable Clinical Outcomes in Patients with Immune Checkpoint Inhibitor-Induced Colitis

R. Bresalier, Xuemei Wang, B. Lashner, 2019, Gastroenterology.

Reducing the Spread of Internet Misinformation in IBD: Ethics and Responsibility.

M. Bewtra, E. Kodish, B. Lashner, 2021, Inflammatory bowel diseases.

Antiviral Treatment for Colonic Cytomegalovirus Infection in Ulcerative Colitis Patients Significantly Improved Their Surgery Free Survival

N. Aggarwal, B. Shen, B. Lashner, 2016, Journal of clinical gastroenterology.

Cancer mortality rates in ulcerative colitis surveillance programs.

B. Lashner, B A Lashner, A Brzezinski, 1994, Gastroenterology.

We are IntechOpen, the world’s leading publisher of Open Access books Built by scientists, for scientists

B. Lashner, A. Atreja, Sansrita Nepal, 2022 .

Urinary Excretion of A^-Acetylspermidine and Other Acetylated and Free Polyamines in the 1,2-Dimethylhydra/inc Model of Experimental Rat Colon Cancer1

P. Dudeja, A. Halline, T. Brasitus, 2006 .

CMV in IBD—Passenger or Pathogen?

B. Lashner, A. Kandiel, 2012 .

Case Report: Can Colectomy Cure Immune Thrombocytopenic Purpura in a Patient with Ulcerative Colitis?

B. Lashner, W. Bauer, A. Litchtin, 1999, Digestive Diseases and Sciences.

Avoiding Narcotics in Crohn’s Disease

B. Lashner, M. Rizk, Whitney E. Jackson, 2013, Journal of clinical gastroenterology.

Worsening risk for the development of dysplasia or cancer in patients with chronic ulcerative colitis.

B. Lashner, B A Lashner, A Brzezinski, 1995, The American journal of gastroenterology.

Crohn's Disease-Associated Genetic Marker is Seen in Medically Unresponsive Ulcerative Colitis Patients and May Be Associated with Pouch-Specific Complications

J. Achkar, B. Lashner, 1999 .

Colorectal Cancer in Ulcerative Colitis: Surveillance

A. Watson, P. Collins, B. Lashner, 2019, Evidence-based Gastroenterology and Hepatology 4e.

Should patients with Crohn's disease be in colonoscopic surveillance programs?

B. Lashner, 2008, Inflammatory Bowel Diseases.

Real-world effectiveness and safety of ustekinumab and vedolizumab in elderly patients with Crohn’s disease

M. Regueiro, J. Achkar, F. Rieder, 2023, Indian Journal of Gastroenterology.

Propylthiouracil for alcoholic liver disease.

Y. Israel, L. Blendis, H. Orrego, 1988, New England Journal of Medicine.

Autologous hematopoietic stem cell transplantation for Crohn's disease: high risk for a high reward.

B. Lashner, 2005, Inflammatory bowel diseases.

A proposed classification of ileal pouch disorders and associated complications after restorative proctocolectomy.

V. Fazio, F. Remzi, I. Lavery, 2008, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

Safety and efficacy of recombinant human interleukin 10 in chronic active Crohn's disease. Crohn's Disease IL-10 Cooperative Study Group.

P. Rutgeerts, O. Nielsen, S. V. van Deventer, 2000, Gastroenterology.

Once-daily dosing of delayed-release oral mesalamine (400-mg tablet) is as effective as twice-daily dosing for maintenance of remission of ulcerative colitis.

J. Korzenik, J. Leighton, D. Ramsey, 2010, Gastroenterology.